Valneva (VALN) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Valneva (VALN) is Neutral.

The composite score behind that read is -0.18, weighing +0.04 of bullish evidence against -0.19 bearish.

Valneva last closed at $5.82, +1.39% on the session.

Against the IVW growth benchmark the position is +0.47% over the forecast window.

The read is built from 12 underlying insights — 1 bullish and 11 bearish.

Agreement across those insights is 92%.

16 graded predictions for VALN so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Valneva in the 6th percentile on return on equity, where 100 is best.

Valneva is classified under Health Care / Biotechnology, with a market capitalisation of $544.28M.

StockMap tracks Valneva as the 160th largest of the 344 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 180 Moderate Underperform, 152 Neutral, 11 Strong Underperform and 1 Moderate Outperform.

On that composite Valneva ranks 151st of 344 in the group, against a group median of -0.21.